96-30125. Intent to Grant an Exclusive License to SciClone Pharmaceuticals

[Federal Register Volume 61, Number 229 (Tuesday, November 26, 1996)]
[Notices]
[Page 60095]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-30125]


-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Intent to Grant an Exclusive License to SciClone Pharmaceuticals

AGENCY: Office of The Judge Advocate General, Defense.

ACTION: Notice of Intent.

-----------------------------------------------------------------------

SUMMARY: In compliance with 37 CFR Sec. 404 et seq., the Department of 
the Army hereby gives notice of its intent to grant to SciClone 
Pharmaceuticals, a corporation having its principal place of business 
at 90 Mariner's Island Blvd., San Mateo, CA 94404, an exclusive license 
under U.S. Patent Applications Serial Numbers 07/878,372 filed 4 May 
1992 and 08/145,660 filed 4 November 1993 respectively, and all 
continuations, continuations-in-part, divisionals, and reissues of the 
same, and all corresponding foreign patent applications which have been 
or will be filed. These applications relate to a composition for and a 
method of treating hepatitis C. Objections along with supporting 
evidence, if any, should be filed within 60 days from the date of this 
notice.

FOR FURTHER INFORMATION CONTACT:
Earl T. Reichert, Intellectual Property Law Division, Office of The 
Judge Advocate General, DA ATTN: JALS-IP, 901 North Stuart Street 
Arlington, VA 22203-1837.

SUPPLEMENTARY INFORMATION: None.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 96-30125 Filed 11-25-96; 8:45 am]
BILLING CODE 3710-08-M